Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abcellera Biologics Inc (NQ: ABCL )

5.000 +0.090 (+1.83%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,438,497
Open 4.930
Bid (Size) 4.900 (1)
Ask (Size) 5.250 (5)
Prev. Close 4.910
Today's Range 4.880 - 5.000
52wk Range 4.880 - 14.97
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron
From AbCellera Biologics Inc.
Via Business Wire
AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology
From AbCellera Biologics Inc.
Via Business Wire

Performance

YTD
-47.31%
-47.31%
1 Month
-9.09%
-9.09%
3 Month
-27.64%
-27.64%
6 Month
-34.04%
-34.04%
1 Year
-45.65%
-45.65%

More News

Read More
Why AbCellera Biologics Is Still A Buy Despite Dropping Royalties: Analyst On Long-Term Prospects
Via Benzinga
3 AI Stocks You’ll Regret Not Buying Soon
Via InvestorPlace
Earnings Preview: AbCellera Biologics
Via Benzinga
Recap: AbCellera Biologics Q1 Earnings
Via Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Apple, Fortinet, Microchip Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
AbCellera Biologics (ABCL) Q2 2023 Earnings Call Transcript
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
AbCellera Reports Q2 2023 Business Results
From AbCellera Biologics Inc.
Via Business Wire
AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing
From AbCellera Biologics Inc.
Via Business Wire
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom
Via InvestorPlace
AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023
From AbCellera Biologics Inc.
Via Business Wire
AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023
From AbCellera Biologics Inc.
Via Business Wire
AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients
From AbCellera Biologics Inc.
Via Business Wire
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
7 Growth Stocks That Could Double Your Money in 2023
Via InvestorPlace
AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript
Via The Motley Fool
AbCellera Reports Q1 2023 Business Results
From AbCellera Biologics Inc.
Via Business Wire
How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies
Via The Motley Fool
7 Stocks Under $10 That Analysts Love
Via InvestorPlace
AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023
From AbCellera Biologics Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.